PBM Conflict Of Interest Study Begins: FTC Contacting 20 PBMs, Pharmacies
This article was originally published in The Pink Sheet Daily
Executive Summary
The Federal Trade Commission will study whether using a PBM-owned mail order pharmacy costs more than using a non-PBM mail order or retail pharmacy. The study was mandated by the Medicare Rx law.
You may also be interested in...
PBM-Owned Mail Order Pharmacies Do Not Result In Higher Costs – FTC
PDP sponsors generally paid less for drugs purchased through PBM-owned mail order pharmacies in 2002 and 2003 than for drugs purchased through mail-order or retail pharmacies not owned by PBMs, according to an FTC report.
PBM-Owned Mail Order Pharmacies Do Not Result In Higher Costs – FTC
PDP sponsors generally paid less for drugs purchased through PBM-owned mail order pharmacies in 2002 and 2003 than for drugs purchased through mail-order or retail pharmacies not owned by PBMs, according to an FTC report.
FTC Should Expand Study Of PBM Business Practices, Senators Say
The commission should initiate a second round of data collection focusing on contracts between PBMs and manufacturers, a letter signed by seven senators states. FTC also is urged to collect data on PBM pricing practices for generics.